The Autoantibodyome: New Insights Into Neurodegeneration

A study published in iScience identified shared patterns of autoantibody activity across multiple sclerosis (MS), Alzheimer’s disease, and Parkinson’s disease, providing new insight into the relationship between immune dysfunction and neurodegeneration.

Researchers from the University of São Paulo and collaborating institutions analyzed five existing datasets comprising 596 samples from individuals with these neurological conditions and healthy controls. Using an integrative approach, they examined the autoantibodyome, the collection of antibodies that recognize the body’s own proteins, to identify similarities and differences in immune activity across the three diseases.

Shared Autoantibody Patterns Reveal Connections Between Immune and Neurological Dysfunction

The researchers identified 17 autoantibodies with consistently increased reactivity and 25 with decreased reactivity across all three diseases. These shared signatures were associated with immune cell activation, inflammatory signaling, and biological processes involved in maintaining the blood-brain barrier, which helps regulate the movement of substances between the bloodstream and the brain.

The analysis also revealed disease-specific patterns associated with neurological functions, including short-term memory in Alzheimer’s disease, muscle contraction in Parkinson’s disease, and pain perception in MS.

Differences in autoantibody activity across disease stages suggest that these immune signatures may change as neurological conditions progress.

Another significant finding involved autoantibodies targeting proteins associated with neurotransmitter pathways, including GABA, glutamate, serotonin, and dopamine. These chemical messengers are essential for communication between nerve cells. The findings suggest that circulating autoantibodies may reflect disruptions in neurological signaling and could potentially interact with proteins involved in these processes.

Previous research has shown that autoantibodies are also present in healthy individuals and do not necessarily cause disease. A 2022 study published in Cell Reports identified 77 commonly occurring autoantibodies in healthy individuals, highlighting the importance of distinguishing normal immune activity from disease-associated patterns. This distinction is particularly relevant as researchers investigate whether specific autoantibody signatures could help identify neurological conditions or provide insight into their underlying mechanisms.

Implications for Autoimmune Disease Research

While MS is an established immune-mediated disease, Alzheimer’s and Parkinson’s diseases are not generally classified as autoimmune. However, growing evidence suggests that immune dysfunction contributes to their development and progression.

By identifying overlapping autoantibody signatures across these conditions, the study strengthens the rationale for investigating shared neuroimmune mechanisms. The findings also highlight the potential of circulating autoantibodies as blood-based biomarkers for understanding neurological disease activity, distinguishing disease stages, and identifying pathways for further research.

Importantly, the study did not establish whether the identified autoantibodies directly cause neurological damage or serve as indicators of underlying disease processes. Further experimental and clinical research is needed to determine their functional effects and potential diagnostic or therapeutic applications.

Citations

Nakanishi Usuda, J., Nóbile, A. L., Nery do Vale, F. Y., Corrêa, Y. L. G., Adri, A. S., Nava, R. G., de Albuquerque Freitas, D. G., Santos, R. S., Schimke, L. F., Fonseca, D. L. M., Cabral-Miranda, G., Khan, T. A., Câmara, N. O., Moll, G., Marques, A. H. C., Dalmolin, R. J. S., Nakaya, H. I., Riemekasten, G., Filgueiras, I. S., Dias, H. D., … Cabral-Marques, O. (2026). Integrative analysis reveals the autoantibodyome neuroimmune signature of neurodegeneration. iScience, 29(2), 114781. https://doi.org/10.1016/j.isci.2026.114781

Shome, M., Chung, Y., Chavan, R., Park, J. G., Qiu, J., & LaBaer, J. (2022). Serum autoantibodyome reveals that healthy individuals share common autoantibodies. Cell reports, 39(9), 110873. https://doi.org/10.1016/j.celrep.2022.110873